Spreadin' the news
Related tables, figures and sidebars
Thursday, January 19, 2012
One of the most active areas of strategic
repositioning in the translational space in 2011 occurred at the level of
public-private partnerships established to expand corporate research portfolios
and strengthen institutional research programs.
Follow the money
SciBX 5(3); doi:10.1038/scibx.2012.59 Published online Jan. 19,
J. SciBX 5(2); doi:10.1038/scibx.2012.31
L. SciBX 4(4); doi:10.1038/scibx.2011.92
C. SciBX 4(15); doi:10.1038/scibx.2011.417
COMPANIES AND INSTITUTIONS MENTIONED
Ascletis Inc., Chapel Hill, N.C.
University, New York, N.Y.
Hangzhou Binjiang Investment Holding Co. Ltd., Hangzhou, China
Huya Bioscience International LLC, San Diego, Calif.
Rockefeller University, New York, N.Y.
Sanofi (Euronext:SAN; NYSE:SNY), Paris, France
California, San Francisco, Calif.
Cornell Medical College, New York, N.Y.
All contents Copyright © 1993-2017 BioCentury Publications, Inc. ALL RIGHTS RESERVED. All use of this Web Site and its contents is governed by the BioCentury User Agreement
. The contents of this Web Site are protected under U.S. and foreign copyright and intellectual property laws, and no part of this Web Site or its contents may be photocopied, reproduced or retransmitted in any form without the written consent of BioCentury, which may be requested from Reprints/Permissions
. BioCentury®; The Bernstein Report on BioBusiness™; The BioCentury 100™; The Clear Route to ROI™; Because Real Intelligence is Hard to Find™; BCIQ™; and BioPharma's Knowledge Center™; are trademarks of BioCentury Publications, Inc., P.O. Box 1246, San Carlos, CA 94070. SciBX® and SciBX: Science-Business eXchange® are trademarks of Nature America, Inc. that are jointly used by BioCentury Publications, Inc. and Nature America, Inc.
Thanks for purchasing this article.
Please bookmark this url for future reference.
We have also sent you a confirming e-mail with a receipt and this same url for your
close [ X ]